ERRATUM.
- Published in:
- 2020
- Publication type:
- Correction Notice
Works matching IS 08991987 AND DT 2020 AND VI 59 AND IP 8
Results: 14
1
2
USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51‐AKT1 signaling.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 1000, doi. 10.1002/mc.23230
- By:
- Publication type:
- Article
3
Hepatocyte nuclear factor‐1β suppresses the stemness and migration of colorectal cancer cells through promoting miR‐200b activity.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 989, doi. 10.1002/mc.23229
- By:
- Publication type:
- Article
4
Nonreceptor protein tyrosine phosphatases (NRPTPs) gene family associates with the risk of hepatocellular carcinoma in a Chinese hepatitis B virus‐related subjects.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 980, doi. 10.1002/mc.23228
- By:
- Publication type:
- Article
5
Inhibition of p62/SQSTM1 sensitizes small‐cell lung cancer cells to cisplatin‐induced cytotoxicity by targeting NEDD9 expression.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 967, doi. 10.1002/mc.23215
- By:
- Publication type:
- Article
6
Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 955, doi. 10.1002/mc.23214
- By:
- Publication type:
- Article
7
Nicotinamide N‐methyltransferase decreases 5‐fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 940, doi. 10.1002/mc.23209
- By:
- Publication type:
- Article
8
Genetic variants of the peroxisome proliferator‐activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 930, doi. 10.1002/mc.23208
- By:
- Publication type:
- Article
9
Alternative splicing related genetic variants contribute to bladder cancer risk.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 923, doi. 10.1002/mc.23207
- By:
- Publication type:
- Article
10
Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA‐30a in breast cancer.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 908, doi. 10.1002/mc.23203
- By:
- Publication type:
- Article
11
ARNT‐dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 897, doi. 10.1002/mc.23201
- By:
- Publication type:
- Article
12
A novel terpenoid class for prevention and treatment of KRAS‐driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 886, doi. 10.1002/mc.23200
- By:
- Publication type:
- Article
13
USF1‐induced overexpression of long noncoding RNA WDFY3‐AS2 promotes lung adenocarcinoma progression via targeting miR‐491‐5p/ZNF703 axis.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 875, doi. 10.1002/mc.23181
- By:
- Publication type:
- Article
14
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 8, p. 871, doi. 10.1002/mc.23059
- Publication type:
- Article